Early identification and referral of liver disease in infants
This Guidelines summary is based on guidance included within the Children’s Liver Disease Foundation Yellow Alert Pack, written to provide general guidelines on the early identification of liver disease in infants and their referral where appropriate.
CLDF guideline: Yellow Alert stool chart
A summary of the CLDF's Yellow Alert stool chart—for tracking the colour of newborn babies' stools and being alert to warning signs of prolonged jaundice.
NICE non-alcoholic fatty liver disease guideline
A summary of NICE guidance on non-alcoholic fatty liver disease. Includes identification, lifestyle advice, and pharmacological treatment.
Nurses play a crucial role in reducing the burden of liver disease
Michelle Clayton examines the current and future impact of liver disease and its causes, and highlights the role of nurses in educating and supporting patients to prevent the disease developing.
NICE cirrhosis guideline
A useful and concise summary on the assessment and management of cirrhosis. Recommendations cover diagnosis, monitoring, and managing complications.
Educational resources
Management of hepatic encephalopathy in primary care
This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
View TARGAXAN® (rifaximin-α) prescribing and adverse event reporting information
UK-HEP-XIF-2100040 October 2021
Half-day virtual event focusing on practical approaches to management of gastrointestinal disorders and iron deficiency
Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines.
UK-COR-NP-2100043
Date of preparation: July 2021